Medgend Icon

Ledgend of Medicine







discontinued


Octreotide Acetate Preservative Free FDA Approved Drugs

OCTREOTIDE ACETATE [Octreotide AcetateC49H66N10O10S2C2H4O2]
RX
-
eq 0.05mg base/ml (injection injectable)
eq 0.1mg base/ml (injection injectable)
eq 0.2mg base/ml (injection injectable)
eq 0.5mg base/ml (injection injectable)
eq 1mg base/ml (injection injectable)
Sun Pharm IndsAug 14, 2007
Teva Pharms UsaOct 3, 2005
Fresenius Kabi UsaFeb 10, 2006
Sagent PharmsNov 12, 2013
West-ward Pharms IntApr 8, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OCTREOTIDE ACETATE (PRESERVATIVE FREE) [Octreotide AcetateC49H66N10O10S2C2H4O2]
RX
-
eq 0.05mg base/ml (injection injectable)
eq 0.1mg base/ml (injection injectable)
eq 0.5mg base/ml (injection injectable)
Fresenius Kabi UsaFeb 10, 2006
Mylan InstitutionalFeb 10, 2011
Sagent PharmsNov 12, 2013
West-ward Pharms IntMar 28, 2005
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SANDOSTATIN [Octreotide AcetateC49H66N10O10S2C2H4O2]
RX
-
eq 0.05mg base/ml (injection injectable)
eq 0.1mg base/ml (injection injectable)
eq 0.2mg base/ml (injection injectable)
eq 0.5mg base/ml (injection injectable)
eq 1mg base/ml (injection injectable)
NovartisOct 21, 1988
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

SANDOSTATIN LAR [Octreotide AcetateC49H66N10O10S2C2H4O2]
RX
-
eq 10mg base/vial (injection injectable)
eq 20mg base/vial (injection injectable)
eq 30mg base/vial (injection injectable)
NovartisNov 25, 1998
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.